Vanguard Global Advisers
USNA icon

Vanguard Global Advisers’s Usana Health Sciences USNA Stock Holding History

Vanguard Global Advisers’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
70,940
+9,782
+16% +$184K ﹤0.01% 1464
2026
Q1 		$1.07M Buy
+61,158
New +$1.21M ﹤0.01% 1620

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Global Advisers's USNA Position: Q2 2026 in Review

Vanguard Global Advisers increased its Usana Health Sciences (USNA) stake by 16% in Q2 2026, buying an estimated $184K and bringing the position to 70,940 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

Vanguard Global Advisers first reported a position in USNA in Q1 2026 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Vanguard Global Advisers held 70,940 shares of Usana Health Sciences worth $1.51M as of Q2 2026.
  • Vanguard Global Advisers bought 9,782 Usana Health Sciences shares in Q2 2026, an estimated $184K.
  • Usana Health Sciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1464 holding.
  • Vanguard Global Advisers first reported a position in Usana Health Sciences in Q1 2026 and has held it in 2 quarters since.
  • 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.